Corporate News 29-Aug-22
Medicamen Biotech to conduct AGM
On 27 September 2022
Medicamen Biotech announced that the 29th Annual General Meeting (AGM) of the company will be held on 27 September 2022.
Previous News
Medicamen Biotech consolidated net profit rises 41.45% in the March 2023 quarter
( Results - Announcements 30-May-23 07:39 )
Medicamen Biotech standalone net profit rises 47.27% in the March 2023 quarter
( Results - Announcements 29-May-23 17:47 )
Divis Laboratories Ltd Slips 7.72%, S&P BSE Healthcare index Shed 1.43%
( Hot Pursuit - 08-Nov-21 09:45 )
Medicamen Biotech consolidated net profit declines 0.53% in the December 2022 quarter
( Results - Announcements 10-Feb-23 16:52 )
Medicamen Biotech announces board meeting date
( Corporate News - 24-Jun-20 14:50 )
Medicamen Biotech fixes record date for interim dividend
( Market Beat - Reports 03-Aug-17 17:11 )
Medicamen Biotech to declare Quarterly Result
( Corporate News - 12-Nov-18 14:47 )
Medicamen Biotech schedules board meeting
( Corporate News - 09-Dec-17 10:46 )
Medicamen Biotech reports net loss of Rs 0.43 crore in the December 2013 quarter
( Results - Announcements 14-Feb-14 19:41 )
Medicamen Biotech reports net loss of Rs 1.27 crore in the March 2013 quarter
( Results - Announcements 31-May-13 12:44 )
Medicamen Biotech to discuss results
( Corporate News - 25-May-18 14:07 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
